Successful response of upadacitinib in the treatment of atopic dermatitis lesions involving sensitive and visible areas resistant to dupilumab.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and experimental dermatology"
DOI: 10.1093/ced/llad040
Abstract: Beneficial effects of upadacitinib in the treatment of atopic dermatitis (AD) patients who resulted unresponsive to dupilumab therapy have been described. AD lesions resistant to dupilumab and localized in sensitive and visible areas showed a… read more here.
Keywords: upadacitinib treatment; treatment atopic; sensitive visible; visible areas ... See more keywords
Upadacitinib in the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2023 at "Dermatologic Therapy"
DOI: 10.1155/2023/9955597
Abstract: Background. The pathogenesis of atopic dermatitis (AD) is associated with proinflammatory cytokines and the JAK/STAT signaling pathway. Upadacitinib, an approved oral JAK1 inhibitor, has been investigated in some clinical trials and observational studies of AD.… read more here.
Keywords: atopic dermatitis; treatment; meta analysis; upadacitinib treatment ... See more keywords
Lymphomatoid papulosis during upadacitinib treatment for rheumatoid arthritis
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Dermatology"
DOI: 10.1684/ejd.2022.4238
Abstract: 142 EJD, vol. 32, n◦ 1, January-February 2022 1. Ruzicka T, Larsen FG, Galewicz D, et al. Oral alitretinoin (9cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a… read more here.
Keywords: treatment rheumatoid; upadacitinib treatment; lymphomatoid papulosis; rheumatoid arthritis ... See more keywords